Greenlane Holdings, Inc. (GNLN)


Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Greenlane Holdings, Inc. To Contact The Firm 

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Greenlane Holdings, Inc. (“Greenlane” or the “Company”) (NASDAQ: GNLN) of the November 12, 2019 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. 

If you invested in acquired Greenlane common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the “Registration Statement”) issued in connection with the Company’s April 2019 initial public offering (“IPO” or the “Offering”), and would like to discuss your legal rights, please fill out the form below.  There is no cost or obligation to you. You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to rgonnello@faruqilaw.com.

The lawsuit has been filed in the U.S. District Court for the Southern District of Florida on behalf of all those who acquired Greenlane common stock pursuant and/or traceable to the registration statement and prospectus issued in connection with the Company’s April 2019 initial public offering. The case, Hammond v. Greenlane Holdings, Inc., No. 19-cv-81259 was filed on September 11, 2019.

The lawsuit focuses on whether the Company and its executives violated federal securities laws by failing to disclose to investors: (1) that the City of San Francisco had introduced a major initiative to ban  the sale of e-cigarette products across three major cities and prohibit the manufacture of products at the headquarters  of Greenlane’s key partner, JUUL Labs; (2) that, if approved, the initiative would materially and adversely impact the  Company’s financial results and prospects; and (3) that, as a result of the foregoing, Defendants’ positive statements  about the Company’s business, operations, and prospects, were materially misleading and/or lacked a reasonable  basis.

On April 22, 2019, the Company filed its prospectus on Form 424B4 with the SEC, which forms part of the Registration Statement. In the IPO, the Company sold approximately 6.45 million shares of common stock at a price of $17.00 per share. The Company received proceeds of approximately $110 million from the Offering, net of underwriting discounts and commissions. The proceeds from the IPO were purportedly to be used for capital improvements to its warehouses and other facilities, capital expenditures relating to its information technology systems, working capital, and general corporate purposes.

On June 18, 2019, the San Francisco Board of Supervisors unanimously approved the ban on the sale and distribution of e-cigarette products within the city. It also endorsed a ban on the manufacturing of e-cigarette products on city property.

On this news, Greenlane stock fell from $13.27 on June 18, 2019 to $11.00 on June 19, 2019—a $2.27 or a 17.11% drop. The stock continued to decline over the course of the next three trading sessions, dropping $1.68 or 15.27%, to close at $9.32 on June 24, 2019.

Contact us

Greenlane Holdings, Inc. (GNLN)

Loading captcha, please wait...

* The submission of this form does not create an attorney-client relationship.

Details

Filed on 09/13/2019

Ticker NASDAQ:GNLN

Office

685 Third Avenue 26th Floor

10017 New York, New York

Phone (212) 983-9330

Fax (212) 983-9331

Counsel

Richard W. Gonnello rgonnello@faruqilaw.com Phone (212) 983-9330 Fax (212) 983-9331

Finding us

Our Offices


Our offices are nationwide. If you have any questions about a case or our firm, please contact us.

New York

685 Third Avenue 26th Floor
New York, New York 10017
(212) 983-9330
(877) 247-4292
(212) 983-9331

California

10866 Wilshire Boulevard Suite 1470
Los Angeles, California 90024
(424) 256-2884
(424) 256-2885

Delaware

3828 Kennett Pike Suite 201
Wilmington, Delaware 19807
(302) 482-3182
(302) 482-3612

Georgia

3975 Roswell Rd Suite A
Atlanta, Georgia 30342
(404) 847-0617
(404) 506-9534

Pennsylvania

1617 JFK Boulevard, Suite 1550
Philadelphia, Pennsylvania 19103
(215) 277-5770
(215) 277-5771

Faruqi & Faruqi office in New York, New York

Faruqi & Faruqi office in Los Angeles, California

Faruqi & Faruqi office in Wilmington, Delaware

Faruqi & Faruqi office in Atlanta, Georgia

Faruqi & Faruqi office in Philadelphia, Pennsylvania